Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Ophthalmology. 2009 Oct 7;116(12):2386–2392. doi: 10.1016/j.ophtha.2009.05.031

Table 3.

Effect of Randomized Aspirin Assignment on Visually Significant AMD by Subgroups.


No. of AMD/Total




Aspirin (N=19,716)
Placebo (N=19,705)
RR*
95% CI
P-value
Age, y
        45−54 9/11,959 20/11,948 0.46 0.21−0.99 0.05
        55−64 39/5,806 39/5,801 1.00 0.64−1.55 0.98
        ∃65
63/1,951
75/1,956
0.84
0.60−1.17
0.30
Smoke Cigarettes
        Current 16/2,558 25/2,633 0.73 0.39−1.38 0.34
        Past/Never
95/17,143
108/17,052
0.86
0.65−1.14
0.29
Alcohol Use
        <1/wk 67/11,493 88/11,455 0.75 0.55−1.03 0.08
      ∃1/wk
44/8,218
46/8,245
0.97
0.64−1.47
0.88
Body-mass index
        <25.0 48/9,803 72/9,826 0.67 0.46−0.96 0.03
        25.0−29.9 32/5,967 36/5,985 0.86 0.54−1.39 0.54
        ∃30.0
28/3,535
25/3,504
1.16
0.68−2.00
0.58
Hypertension
        Yes 51/5,093 50/5,032 0.99 0.67−1.46 0.94
        No
60/14,617
84/14,670
0.73
0.52−1.01
0.06
Hyperlipidemia
        Yes 40/5,858 53/5,697 0.77 0.51−1.16 0.20
        No
71/13,848
81/14,002
0.86
0.63−1.19
0.37
Diabetes
        Yes 4/514 5/477 0.77 0.21−2.87 0.69
        No
107/19,190
129/19,216
0.83
0.64−1.07
0.15
Menopausal status and use of HT
        Premenopausal 3/5,456 7/5,465 0.43 0.11−1.65 0.22
        Uncertain 7/3,493 8/3,595 0.89 0.32−2.45 0.82
        Postmenopausal and current HT 33/5,967 44/5,832 0.74 0.47−1.16 0.18
        Postmenopausal and no HT
68/4,752
75/4,761
0.91
0.65−1.26
0.56
Parental history of MI before 60 yrs of age
        Yes 9/2,299 13/2,286 0.82 0.35−1.92 0.64
        No
93/15,381
101/15,458
0.90
0.68−1.19
0.46
Multivitamin Use
        Current 50/7,155 46/7,110 1.14 0.76−1.70 0.53
        Past/Never
61/12,289
87/12,313
0.68
0.49−0.95
0.02
Eye exam in past 2 yrs
        Yes 97/16,307 112/16,276 0.86 0.66−1.13 0.29
        No 14/3,408 22/3,423 0.64 0.33−1.25 0.19

Abbreviations: AMD, age-related macular degeneration; CI, confidence interval; HT, hormone therapy; MI, myocardial infarction.

*

Adjusted for age and vitamin E and beta carotene treatment assignment.